Upon phosphorylation by GSK3β, β-catenin is degraded via the ubiquitin-proteasome system; GSK3β is therefore recognized as a key player in the regulation of β-catenin function, particularly in the promotion of cancer growth [27]. The gene discussed is GSK3B; the disease is cancer.